Pulmonx Corporation
LUNG
$7.05
-$0.27-3.69%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.57% | -1.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.57% | -1.91% | |||
| Cost of Revenue | 15.18% | -2.10% | |||
| Gross Profit | 17.06% | -1.84% | |||
| SG&A Expenses | 6.28% | 0.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.72% | -5.19% | |||
| Operating Income | 5.04% | 9.56% | |||
| Income Before Tax | 5.84% | 8.46% | |||
| Income Tax Expenses | -80.21% | 128.57% | |||
| Earnings from Continuing Operations | 6.85% | 7.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.85% | 7.71% | |||
| EBIT | 5.04% | 9.56% | |||
| EBITDA | 4.42% | 4.80% | |||
| EPS Basic | 7.55% | 8.49% | |||
| Normalized Basic EPS | 6.58% | 9.24% | |||
| EPS Diluted | 7.55% | 8.49% | |||
| Normalized Diluted EPS | 6.58% | 9.24% | |||
| Average Basic Shares Outstanding | 0.78% | 0.86% | |||
| Average Diluted Shares Outstanding | 0.78% | 0.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
